Researchers from Sinai Health have published a study providing an ultra-detailed look at the organization of a living human cell, providing a new tool that can help scientists around the world better understand what happens during disease.
The new study, published in the journal Nature, was conducted in the laboratory of Dr. Anne-Claude Gingras, a senior investigator at the Lunenfeld-Tanenbaum Research Institute and professor in the Department of Molecular Genetics at the University of Toronto.
Job: Scientist in Physical Sciences and Canada Research Chair – Tier 2 in Contrast Agents and Biosensors for Medical Imaging and Image-Guided Therapy (one position) - Sunnybrook Research Institute Toronto, Canada
Canada hosts the world for key research conference
The International Conference on Research Infrastructures will discuss how researchers can collaborate to build bridges to a sustainable world Canada Foundation for Innovation
French
OTTAWA, May 27, 2021 (GLOBE NEWSWIRE) If there is one thing the COVID-19 pandemic has made clear, it is that when researchers around the world come together to share information and data on a common problem, they can quickly make strides in tackling global emergencies. What is also clear is how important it is for researchers to have access to the state-of-the-art labs and facilities they need to generate that knowledge.
RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map
ACCESSWIRE
11 May 2021, 20:05 GMT+10
Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization
VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ) is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ( UBC ) that enables the second stage of its cell marker research. The project is being co-led by RepliCel s Dr. Kevin McElwee and UBC s Professor Youwen Zhou.
(1)
Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization
VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ) is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ( UBC ) that enables the second stage of its cell marker research. The project is being co-led by RepliCel s Dr. Kevin McElwee and UBC s Professor Youwen Zhou.
The project commenced in 2017, is designed to deliver a gene and protein expression map of healthy hair follicle cells expected to be critically important to improving key components of the manufacturing, regulatory, and clinical profile of RepliCel s cell therapy products.